Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger

by Kieran S. O’Brien, Ahmed M. Arzika, Ramatou Maliki, Farouk Manzo, Alio K. Mamkara, Elodie Lebas, Catherine Cook, Robin L. Bailey, Sheila K. West, Catherine E. Oldenburg, Travis C. Porco, Benjamin Arnold, Jeremy D. Keenan, Thomas M. Lietman, for the MORDOR Study Group


Biannual azithromycin distribution has been shown to reduce child mortality as well as increase antimicrobial resistance. Targeting distributions to vulnerable subgroups such as malnourished children is one approach to reaching those at the highest risk of mortality while limiting selection for resistance. The objective of this analysis was to assess whether the effect of azithromycin on mortality differs by nutritional status.

Methods and findings

A large simple trial randomized communities in Niger to receive biannual distributions of azithromycin or placebo to children 1–59 months old over a 2-year timeframe. In exploratory subgroup analyses, the effect of azithromycin distribution on child mortality was assessed for underweight subgroups using weight-for-age Z-score (WAZ) thresholds of −2 and −3. Modification of the effect of azithromycin on mortality by underweight status was examined on the additive and multiplicative scale. Between December 2014 and August 2017, 27,222 children 1–11 months of age from 593 communities had weight measured at their first study visit. Overall, the average age among included children was 4.7 months (interquartile range [IQR] 3–6), 49.5% were female, 23% had a WAZ P P = 0.001) among children with WAZ P = 0.003) among children with WAZ P = 0.34; WAZ P = 0.50, WAZ P = 0.14; WAZ P = 0.26). The estimated number of deaths averted with azithromycin was 388 (95% CI 214 to 574) overall, 116 (95% CI 48 to 192) among children with WAZ Conclusions

READ MORE  Redefining enteroaggregative Escherichia coli (EAEC): Genomic characterization of epidemiological EAEC strains

Although mortality rates were higher in the underweight subgroups, this study was unable to demonstrate that nutritional status modified the effect of biannual azithromycin distribution on mortality. Even if the effect were greater among underweight children, a nontargeted intervention would result in the greatest absolute number of deaths averted.

Trial registration

The MORDOR trial is registered at NCT02047981.

Paper source
Plos Journal

Ominy science editory team

A team of dedicated users that search, fetch and publish research stories for Ominy science.

Copyright 2020 Ominy science

Content published here is for information purposes alone.